MI
MITSUHIRO IYORI
Research areas: Medicine · Public Health, Environmental and Occupational Health · Malaria Research and Control · Immunotherapy and Immune Responses · SARS-CoV-2 and COVID-19 Research
0000-0001-9940-7342
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Evaluation of an E. coli-expressed spike protein-based in-house ELISA system for assessment of antibody responses after COVID-19 infection and vaccination Save
- Evaluation of an E. coli-expressed spike protein-based in-house ELISA system for assessment of antibody responses after COVID-19 infection and vaccination Save
- A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models Save
- Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection Save
- Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection Save
- Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort Save
- Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort Save
- Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort Save
- Down‐selecting circumsporozoite protein‐based malaria vaccine: A comparison of malaria sporozoite challenge model Save
- Baculovirus-Induced Fast-Acting Innate Immunity Kills Liver-Stage Plasmodium Save
- Cover Image Volume 39, Issue 12 Save
- DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice Save
- Protective efficacy of an IL‐12‐expressing baculoviral malaria vaccine Save